Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 162

1.

Projected number of people with onchocerciasis-loiasis co-infection in Africa, 1995 to 2025.

Vinkeles Melchers NVS, Coffeng LE, Boussinesq M, Pedrique B, Pion SDS, Tekle AH, Zouré HGM, Wanji S, Remme JH, Stolk WA.

Clin Infect Dis. 2019 Jul 13. pii: ciz647. doi: 10.1093/cid/ciz647. [Epub ahead of print]

PMID:
31304961
2.

A test-and-not-treat strategy for onchocerciasis elimination in Loa loa co-endemic areas: cost analysis of a pilot in the Soa health district, Cameroon.

Lenk EJ, Moungui HC, Boussinesq M, Kamgno J, Nana-Djeunga HC, Fitzpatrick C, Peultier AMM, Klion AD, Nutman TB, Fletcher DA, Pion SD, Niamsi-Emalio Y, Redekop WK, Severens JL, Stolk WA.

Clin Infect Dis. 2019 Jun 4. pii: ciz461. doi: 10.1093/cid/ciz461. [Epub ahead of print]

PMID:
31165855
3.

Risk factors for lymphatic filariasis in two villages of the Democratic Republic of the Congo.

Chesnais CB, Awaca-Uvon NP, Vlaminck J, Tambwe JP, Weil GJ, Pion SD, Boussinesq M.

Parasit Vectors. 2019 Apr 11;12(1):162. doi: 10.1186/s13071-019-3428-5.

4.

Effect of a Single Standard Dose (150-200 μg/kg) of Ivermectin on Loa loa Microfilaremia: Systematic Review and Meta-analysis.

Pion SD, Tchatchueng-Mbougua JB, Chesnais CB, Kamgno J, Gardon J, Chippaux JP, Ranque S, Ernould JC, Garcia A, Boussinesq M.

Open Forum Infect Dis. 2019 Jan 11;6(4):ofz019. doi: 10.1093/ofid/ofz019. eCollection 2019 Apr.

5.

Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in Cameroon.

Boullé C, Njamnshi AK, Dema F, Mengnjo MK, Siewe Fodjo JN, Bissek AZ, Suykerbuyk P, Lenou-Nanga CG, Nana-Djeunga HC, Kamgno J, Chesnais CB, Boussinesq M, Colebunders R.

Parasit Vectors. 2019 Mar 19;12(1):114. doi: 10.1186/s13071-019-3345-7.

6.

Loa loa microfilariae in skin snips: consequences for onchocerciasis monitoring and evaluation in L. loa endemic areas.

Nana-Djeunga HC, Fossuo-Thotchum F, Pion SD, Chesnais CB, Kubofcik J, Mackenzie CD, Klion AD, Boussinesq M, Nutman TB, Kamgno J.

Clin Infect Dis. 2019 Mar 6. pii: ciz172. doi: 10.1093/cid/ciz172. [Epub ahead of print]

PMID:
30861060
7.

Onchocerciasis-associated epilepsy - Authors' reply.

Chesnais CB, Boussinesq M.

Lancet Infect Dis. 2019 Jan;19(1):22. doi: 10.1016/S1473-3099(18)30743-6. No abstract available.

PMID:
30587288
8.

Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin.

Siewe Fodjo JN, Tatah G, Tabah EN, Ngarka L, Nfor LN, Chokote SE, Mengnjo MK, Dema F, Sitouok AT, Nkoro G, Ntone FE, Bissek AZ, Chesnais CB, Boussinesq M, Colebunders R, Njamnshi AK.

Infect Dis Poverty. 2018 Dec 3;7(1):114. doi: 10.1186/s40249-018-0497-1.

9.

The temporal relationship between onchocerciasis and epilepsy: a population-based cohort study.

Chesnais CB, Nana-Djeunga HC, Njamnshi AK, Lenou-Nanga CG, Boullé C, Bissek AZ, Kamgno J, Colebunders R, Boussinesq M.

Lancet Infect Dis. 2018 Nov;18(11):1278-1286. doi: 10.1016/S1473-3099(18)30425-0. Epub 2018 Sep 26.

PMID:
30268645
10.

How Can Onchocerciasis Elimination in Africa Be Accelerated? Modeling the Impact of Increased Ivermectin Treatment Frequency and Complementary Vector Control.

Verver S, Walker M, Kim YE, Fobi G, Tekle AH, Zouré HGM, Wanji S, Boakye DA, Kuesel AC, de Vlas SJ, Boussinesq M, Basáñez MG, Stolk WA.

Clin Infect Dis. 2018 Jun 1;66(suppl_4):S267-S274. doi: 10.1093/cid/cix1137.

11.

Report of the first international workshop on onchocerciasis-associated epilepsy.

Colebunders R, Mandro M, Njamnshi AK, Boussinesq M, Hotterbeekx A, Kamgno J, O'Neill S, Hopkins A, Suykerbuyk P, Basáñez MG, Post RJ, Pedrique B, Preux PM, Stolk WA, Nutman TB, Idro R.

Infect Dis Poverty. 2018 Mar 22;7(1):23. doi: 10.1186/s40249-018-0400-0.

12.

Treating Onchocerciasis in Regions in Which Loa loa Is Endemic.

Pion SD, Boussinesq M, Kamgno J.

N Engl J Med. 2018 Mar 1;378(9):871-872. doi: 10.1056/NEJMc1716788. No abstract available.

PMID:
29490177
13.

Alternative treatment strategies to accelerate the elimination of onchocerciasis.

Boussinesq M, Fobi G, Kuesel AC.

Int Health. 2018 Mar 1;10(suppl_1):i40-i48. doi: 10.1093/inthealth/ihx054.

14.

Operationalization of the test and not treat strategy to accelerate the elimination of onchocerciasis and lymphatic filariasis in Central Africa.

Kamgno J, Nana-Djeunga HC, Pion SD, Chesnais CB, Klion AD, Mackenzie CD, Nutman TB, Boussinesq M.

Int Health. 2018 Mar 1;10(suppl_1):i49-i53. doi: 10.1093/inthealth/ihx051.

15.

A new powerful drug to combat river blindness.

Boussinesq M.

Lancet. 2018 Oct 6;392(10154):1170-1172. doi: 10.1016/S0140-6736(18)30101-6. Epub 2018 Jan 18. No abstract available.

16.

The Population Biology and Transmission Dynamics of Loa loa.

Whittaker C, Walker M, Pion SDS, Chesnais CB, Boussinesq M, Basáñez MG.

Trends Parasitol. 2018 Apr;34(4):335-350. doi: 10.1016/j.pt.2017.12.003. Epub 2018 Jan 10. Review.

17.

A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa-Endemic Areas.

Kamgno J, Pion SD, Chesnais CB, Bakalar MH, D'Ambrosio MV, Mackenzie CD, Nana-Djeunga HC, Gounoue-Kamkumo R, Njitchouang GR, Nwane P, Tchatchueng-Mbouga JB, Wanji S, Stolk WA, Fletcher DA, Klion AD, Nutman TB, Boussinesq M.

N Engl J Med. 2017 Nov 23;377(21):2044-2052. doi: 10.1056/NEJMoa1705026. Epub 2017 Nov 8.

18.

Familial Aggregation and Heritability of Loa loa Microfilaremia.

Eyebe S, Sabbagh A, Pion SD, Nana-Djeunga HC, Kamgno J, Boussinesq M, Chesnais CB.

Clin Infect Dis. 2018 Feb 10;66(5):751-757. doi: 10.1093/cid/cix877.

PMID:
29040446
19.

Macrofilaricidal Efficacy of Repeated Doses of Ivermectin for the Treatment of River Blindness.

Walker M, Pion SDS, Fang H, Gardon J, Kamgno J, Basáñez MG, Boussinesq M.

Clin Infect Dis. 2017 Nov 29;65(12):2026-2034. doi: 10.1093/cid/cix616.

20.

A multi-center field study of two point-of-care tests for circulating Wuchereria bancrofti antigenemia in Africa.

Chesnais CB, Awaca-Uvon NP, Bolay FK, Boussinesq M, Fischer PU, Gankpala L, Meite A, Missamou F, Pion SD, Weil GJ.

PLoS Negl Trop Dis. 2017 Sep 11;11(9):e0005703. doi: 10.1371/journal.pntd.0005703. eCollection 2017 Sep.

21.

Genome-wide analysis of ivermectin response by Onchocerca volvulus reveals that genetic drift and soft selective sweeps contribute to loss of drug sensitivity.

Doyle SR, Bourguinat C, Nana-Djeunga HC, Kengne-Ouafo JA, Pion SDS, Bopda J, Kamgno J, Wanji S, Che H, Kuesel AC, Walker M, Basáñez MG, Boakye DA, Osei-Atweneboana MY, Boussinesq M, Prichard RK, Grant WN.

PLoS Negl Trop Dis. 2017 Jul 26;11(7):e0005816. doi: 10.1371/journal.pntd.0005816. eCollection 2017 Jul.

22.

Effect of 3 years of biannual mass drug administration with albendazole on lymphatic filariasis and soil-transmitted helminth infections: a community-based study in Republic of the Congo.

Pion SDS, Chesnais CB, Weil GJ, Fischer PU, Missamou F, Boussinesq M.

Lancet Infect Dis. 2017 Jul;17(7):763-769. doi: 10.1016/S1473-3099(17)30175-5. Epub 2017 Mar 31.

PMID:
28372977
23.

Still mesoendemic onchocerciasis in two Cameroonian community-directed treatment with ivermectin projects despite more than 15 years of mass treatment.

Kamga GR, Dissak-Delon FN, Nana-Djeunga HC, Biholong BD, Mbigha-Ghogomu S, Souopgui J, Zoure HG, Boussinesq M, Kamgno J, Robert A.

Parasit Vectors. 2016 Nov 14;9(1):581.

24.

Excess mortality associated with loiasis: a retrospective population-based cohort study.

Chesnais CB, Takougang I, Paguélé M, Pion SD, Boussinesq M.

Lancet Infect Dis. 2017 Jan;17(1):108-116. doi: 10.1016/S1473-3099(16)30405-4. Epub 2016 Oct 21.

PMID:
27777031
25.

Positivity of Antigen Tests Used for Diagnosis of Lymphatic Filariasis in Individuals Without Wuchereria bancrofti Infection But with High Loa loa Microfilaremia.

Pion SD, Montavon C, Chesnais CB, Kamgno J, Wanji S, Klion AD, Nutman TB, Boussinesq M.

Am J Trop Med Hyg. 2016 Dec 7;95(6):1417-1423. doi: 10.4269/ajtmh.16-0547. Epub 2016 Oct 10.

26.

Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results.

Tekle AH, Zouré HG, Noma M, Boussinesq M, Coffeng LE, Stolk WA, Remme JH.

Infect Dis Poverty. 2016 Jun 27;5(1):66. doi: 10.1186/s40249-016-0160-7.

27.

Familial Aggregation and Heritability of Wuchereria bancrofti Infection.

Chesnais CB, Sabbagh A, Pion SD, Missamou F, Garcia A, Boussinesq M.

J Infect Dis. 2016 Aug 15;214(4):587-94. doi: 10.1093/infdis/jiw212. Epub 2016 May 26.

PMID:
27230098
28.

Measurement of Circulating Filarial Antigen Levels in Human Blood with a Point-of-Care Test Strip and a Portable Spectrodensitometer.

Chesnais CB, Vlaminck J, Kunyu-Shako B, Pion SD, Awaca-Uvon NP, Weil GJ, Mumba D, Boussinesq M.

Am J Trop Med Hyg. 2016 Jun 1;94(6):1324-1329. doi: 10.4269/ajtmh.15-0916. Epub 2016 Apr 25.

29.

Model-Based Geostatistical Mapping of the Prevalence of Onchocerca volvulus in West Africa.

O'Hanlon SJ, Slater HC, Cheke RA, Boatin BA, Coffeng LE, Pion SD, Boussinesq M, Zouré HG, Stolk WA, Basáñez MG.

PLoS Negl Trop Dis. 2016 Jan 15;10(1):e0004328. doi: 10.1371/journal.pntd.0004328. eCollection 2016 Jan.

30.

Point-of-care quantification of blood-borne filarial parasites with a mobile phone microscope.

D'Ambrosio MV, Bakalar M, Bennuru S, Reber C, Skandarajah A, Nilsson L, Switz N, Kamgno J, Pion S, Boussinesq M, Nutman TB, Fletcher DA.

Sci Transl Med. 2015 May 6;7(286):286re4. doi: 10.1126/scitranslmed.aaa3480.

PMID:
25947164
31.

The impact of two semiannual treatments with albendazole alone on lymphatic filariasis and soil-transmitted helminth infections: a community-based study in the Republic of Congo.

Pion SD, Chesnais CB, Bopda J, Louya F, Fischer PU, Majewski AC, Weil GJ, Boussinesq M, Missamou F.

Am J Trop Med Hyg. 2015 May;92(5):959-66. doi: 10.4269/ajtmh.14-0661. Epub 2015 Mar 9.

32.

Analysis of nematode motion using an improved light-scatter based system.

Nutting CS, Eversole RR, Blair K, Specht S, Nutman TB, Klion AD, Wanji S, Boussinesq M, Mackenzie CD.

PLoS Negl Trop Dis. 2015 Feb 19;9(2):e0003523. doi: 10.1371/journal.pntd.0003523. eCollection 2015 Feb.

33.

Imported loiasis in Italy: an analysis of 100 cases.

Gobbi F, Postiglione C, Angheben A, Marocco S, Monteiro G, Buonfrate D, Mascarello M, Gobbo M, Boussinesq M, Bisoffi Z.

Travel Med Infect Dis. 2014 Nov-Dec;12(6 Pt B):713-7. doi: 10.1016/j.tmaid.2014.07.004. Epub 2014 Aug 1.

PMID:
25131142
34.

The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases.

Hotez PJ, Alvarado M, Basáñez MG, Bolliger I, Bourne R, Boussinesq M, Brooker SJ, Brown AS, Buckle G, Budke CM, Carabin H, Coffeng LE, Fèvre EM, Fürst T, Halasa YA, Jasrasaria R, Johns NE, Keiser J, King CH, Lozano R, Murdoch ME, O'Hanlon S, Pion SD, Pullan RL, Ramaiah KD, Roberts T, Shepard DS, Smith JL, Stolk WA, Undurraga EA, Utzinger J, Wang M, Murray CJ, Naghavi M.

PLoS Negl Trop Dis. 2014 Jul 24;8(7):e2865. doi: 10.1371/journal.pntd.0002865. eCollection 2014 Jul. No abstract available.

35.

A case study of risk factors for lymphatic filariasis in the Republic of Congo.

Chesnais CB, Missamou F, Pion SD, Bopda J, Louya F, Majewski AC, Fischer PU, Weil GJ, Boussinesq M.

Parasit Vectors. 2014 Jul 1;7:300. doi: 10.1186/1756-3305-7-300.

36.

Reproductive status of Onchocerca volvulus after ivermectin treatment in an ivermectin-naïve and a frequently treated population from Cameroon.

Nana-Djeunga HC, Bourguinat C, Pion SD, Bopda J, Kengne-Ouafo JA, Njiokou F, Prichard RK, Wanji S, Kamgno J, Boussinesq M.

PLoS Negl Trop Dis. 2014 Apr 24;8(4):e2824. doi: 10.1371/journal.pntd.0002824. eCollection 2014 Apr.

37.

Absence of an association between Plasmodium falciparum infection and post-ivermectin Loa-related non-neurologic serious adverse events.

Fokom-Domgue J, Pion SD, Gounoue R, Akame J, Nguipdop-Djomo P, Twum-Danso NA, Thylefors B, Boussinesq M, Kamgno J.

Am J Trop Med Hyg. 2014 Feb;90(2):335-8. doi: 10.4269/ajtmh.13-0189. Epub 2014 Jan 13.

38.

Impact of repeated ivermectin treatments against onchocerciasis on the transmission of loiasis: an entomologic evaluation in central Cameroon.

Kouam MK, Tchatchueng-Mbougua JB, Demanou M, Boussinesq M, Pion SD, Kamgno J.

Parasit Vectors. 2013 Sep 27;6(1):283. doi: 10.1186/1756-3305-6-283.

39.

Semi-quantitative scoring of an immunochromatographic test for circulating filarial antigen.

Chesnais CB, Missamou F, Pion SD, Bopda J, Louya F, Majewski AC, Weil GJ, Boussinesq M.

Am J Trop Med Hyg. 2013 Nov;89(5):916-8. doi: 10.4269/ajtmh.13-0245. Epub 2013 Sep 9.

40.

Onchocerciasis: the pre-control association between prevalence of palpable nodules and skin microfilariae.

Coffeng LE, Pion SD, O'Hanlon S, Cousens S, Abiose AO, Fischer PU, Remme JH, Dadzie KY, Murdoch ME, de Vlas SJ, Basáñez MG, Stolk WA, Boussinesq M.

PLoS Negl Trop Dis. 2013 Apr 11;7(4):e2168. doi: 10.1371/journal.pntd.0002168. Print 2013.

41.

Case-control studies on the relationship between onchocerciasis and epilepsy: systematic review and meta-analysis.

Kaiser C, Pion SD, Boussinesq M.

PLoS Negl Trop Dis. 2013;7(3):e2147. doi: 10.1371/journal.pntd.0002147. Epub 2013 Mar 28. Review.

42.

Dynamics of Onchocerca volvulus microfilarial densities after ivermectin treatment in an ivermectin-naïve and a multiply treated population from Cameroon.

Pion SD, Nana-Djeunga HC, Kamgno J, Tendongfor N, Wanji S, Njiokou F, Prichard RK, Boussinesq M.

PLoS Negl Trop Dis. 2013;7(2):e2084. doi: 10.1371/journal.pntd.0002084. Epub 2013 Feb 28.

43.

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M, Anderson HR, Andrews KG, Aryee M, Atkinson C, Bacchus LJ, Bahalim AN, Balakrishnan K, Balmes J, Barker-Collo S, Baxter A, Bell ML, Blore JD, Blyth F, Bonner C, Borges G, Bourne R, Boussinesq M, Brauer M, Brooks P, Bruce NG, Brunekreef B, Bryan-Hancock C, Bucello C, Buchbinder R, Bull F, Burnett RT, Byers TE, Calabria B, Carapetis J, Carnahan E, Chafe Z, Charlson F, Chen H, Chen JS, Cheng AT, Child JC, Cohen A, Colson KE, Cowie BC, Darby S, Darling S, Davis A, Degenhardt L, Dentener F, Des Jarlais DC, Devries K, Dherani M, Ding EL, Dorsey ER, Driscoll T, Edmond K, Ali SE, Engell RE, Erwin PJ, Fahimi S, Falder G, Farzadfar F, Ferrari A, Finucane MM, Flaxman S, Fowkes FG, Freedman G, Freeman MK, Gakidou E, Ghosh S, Giovannucci E, Gmel G, Graham K, Grainger R, Grant B, Gunnell D, Gutierrez HR, Hall W, Hoek HW, Hogan A, Hosgood HD 3rd, Hoy D, Hu H, Hubbell BJ, Hutchings SJ, Ibeanusi SE, Jacklyn GL, Jasrasaria R, Jonas JB, Kan H, Kanis JA, Kassebaum N, Kawakami N, Khang YH, Khatibzadeh S, Khoo JP, Kok C, Laden F, Lalloo R, Lan Q, Lathlean T, Leasher JL, Leigh J, Li Y, Lin JK, Lipshultz SE, London S, Lozano R, Lu Y, Mak J, Malekzadeh R, Mallinger L, Marcenes W, March L, Marks R, Martin R, McGale P, McGrath J, Mehta S, Mensah GA, Merriman TR, Micha R, Michaud C, Mishra V, Mohd Hanafiah K, Mokdad AA, Morawska L, Mozaffarian D, Murphy T, Naghavi M, Neal B, Nelson PK, Nolla JM, Norman R, Olives C, Omer SB, Orchard J, Osborne R, Ostro B, Page A, Pandey KD, Parry CD, Passmore E, Patra J, Pearce N, Pelizzari PM, Petzold M, Phillips MR, Pope D, Pope CA 3rd, Powles J, Rao M, Razavi H, Rehfuess EA, Rehm JT, Ritz B, Rivara FP, Roberts T, Robinson C, Rodriguez-Portales JA, Romieu I, Room R, Rosenfeld LC, Roy A, Rushton L, Salomon JA, Sampson U, Sanchez-Riera L, Sanman E, Sapkota A, Seedat S, Shi P, Shield K, Shivakoti R, Singh GM, Sleet DA, Smith E, Smith KR, Stapelberg NJ, Steenland K, Stöckl H, Stovner LJ, Straif K, Straney L, Thurston GD, Tran JH, Van Dingenen R, van Donkelaar A, Veerman JL, Vijayakumar L, Weintraub R, Weissman MM, White RA, Whiteford H, Wiersma ST, Wilkinson JD, Williams HC, Williams W, Wilson N, Woolf AD, Yip P, Zielinski JM, Lopez AD, Murray CJ, Ezzati M, AlMazroa MA, Memish ZA.

Lancet. 2012 Dec 15;380(9859):2224-60. doi: 10.1016/S0140-6736(12)61766-8. Erratum in: Lancet. 2013 Apr 13;381(9874):1276. Lancet. 2013 Feb 23;381(9867):628. AlMazroa, Mohammad A [added]; Memish, Ziad A [added].

44.

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basáñez MG, Baxter A, Bell ML, Benjamin EJ, Bennett D, Bernabé E, Bhalla K, Bhandari B, Bikbov B, Bin Abdulhak A, Birbeck G, Black JA, Blencowe H, Blore JD, Blyth F, Bolliger I, Bonaventure A, Boufous S, Bourne R, Boussinesq M, Braithwaite T, Brayne C, Bridgett L, Brooker S, Brooks P, Brugha TS, Bryan-Hancock C, Bucello C, Buchbinder R, Buckle G, Budke CM, Burch M, Burney P, Burstein R, Calabria B, Campbell B, Canter CE, Carabin H, Carapetis J, Carmona L, Cella C, Charlson F, Chen H, Cheng AT, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahiya M, Dahodwala N, Damsere-Derry J, Danaei G, Davis A, De Leo D, Degenhardt L, Dellavalle R, Delossantos A, Denenberg J, Derrett S, Des Jarlais DC, Dharmaratne SD, Dherani M, Diaz-Torne C, Dolk H, Dorsey ER, Driscoll T, Duber H, Ebel B, Edmond K, Elbaz A, Ali SE, Erskine H, Erwin PJ, Espindola P, Ewoigbokhan SE, Farzadfar F, Feigin V, Felson DT, Ferrari A, Ferri CP, Fèvre EM, Finucane MM, Flaxman S, Flood L, Foreman K, Forouzanfar MH, Fowkes FG, Fransen M, Freeman MK, Gabbe BJ, Gabriel SE, Gakidou E, Ganatra HA, Garcia B, Gaspari F, Gillum RF, Gmel G, Gonzalez-Medina D, Gosselin R, Grainger R, Grant B, Groeger J, Guillemin F, Gunnell D, Gupta R, Haagsma J, Hagan H, Halasa YA, Hall W, Haring D, Haro JM, Harrison JE, Havmoeller R, Hay RJ, Higashi H, Hill C, Hoen B, Hoffman H, Hotez PJ, Hoy D, Huang JJ, Ibeanusi SE, Jacobsen KH, James SL, Jarvis D, Jasrasaria R, Jayaraman S, Johns N, Jonas JB, Karthikeyan G, Kassebaum N, Kawakami N, Keren A, Khoo JP, King CH, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Laden F, Lalloo R, Laslett LL, Lathlean T, Leasher JL, Lee YY, Leigh J, Levinson D, Lim SS, Limb E, Lin JK, Lipnick M, Lipshultz SE, Liu W, Loane M, Ohno SL, Lyons R, Mabweijano J, MacIntyre MF, Malekzadeh R, Mallinger L, Manivannan S, Marcenes W, March L, Margolis DJ, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGill N, McGrath J, Medina-Mora ME, Meltzer M, Mensah GA, Merriman TR, Meyer AC, Miglioli V, Miller M, Miller TR, Mitchell PB, Mock C, Mocumbi AO, Moffitt TE, Mokdad AA, Monasta L, Montico M, Moradi-Lakeh M, Moran A, Morawska L, Mori R, Murdoch ME, Mwaniki MK, Naidoo K, Nair MN, Naldi L, Narayan KM, Nelson PK, Nelson RG, Nevitt MC, Newton CR, Nolte S, Norman P, Norman R, O'Donnell M, O'Hanlon S, Olives C, Omer SB, Ortblad K, Osborne R, Ozgediz D, Page A, Pahari B, Pandian JD, Rivero AP, Patten SB, Pearce N, Padilla RP, Perez-Ruiz F, Perico N, Pesudovs K, Phillips D, Phillips MR, Pierce K, Pion S, Polanczyk GV, Polinder S, Pope CA 3rd, Popova S, Porrini E, Pourmalek F, Prince M, Pullan RL, Ramaiah KD, Ranganathan D, Razavi H, Regan M, Rehm JT, Rein DB, Remuzzi G, Richardson K, Rivara FP, Roberts T, Robinson C, De Leòn FR, Ronfani L, Room R, Rosenfeld LC, Rushton L, Sacco RL, Saha S, Sampson U, Sanchez-Riera L, Sanman E, Schwebel DC, Scott JG, Segui-Gomez M, Shahraz S, Shepard DS, Shin H, Shivakoti R, Singh D, Singh GM, Singh JA, Singleton J, Sleet DA, Sliwa K, Smith E, Smith JL, Stapelberg NJ, Steer A, Steiner T, Stolk WA, Stovner LJ, Sudfeld C, Syed S, Tamburlini G, Tavakkoli M, Taylor HR, Taylor JA, Taylor WJ, Thomas B, Thomson WM, Thurston GD, Tleyjeh IM, Tonelli M, Towbin JA, Truelsen T, Tsilimbaris MK, Ubeda C, Undurraga EA, van der Werf MJ, van Os J, Vavilala MS, Venketasubramanian N, Wang M, Wang W, Watt K, Weatherall DJ, Weinstock MA, Weintraub R, Weisskopf MG, Weissman MM, White RA, Whiteford H, Wiebe N, Wiersma ST, Wilkinson JD, Williams HC, Williams SR, Witt E, Wolfe F, Woolf AD, Wulf S, Yeh PH, Zaidi AK, Zheng ZJ, Zonies D, Lopez AD, AlMazroa MA, Memish ZA.

Lancet. 2012 Dec 15;380(9859):2197-223. doi: 10.1016/S0140-6736(12)61689-4. Erratum in: Lancet. 2013 Feb 23;381(9867):628. AlMazroa, Mohammad A [added]; Memish, Ziad A [added].

PMID:
23245608
45.

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basáñez MG, Baxter A, Bell ML, Benjamin EJ, Bennett D, Bernabé E, Bhalla K, Bhandari B, Bikbov B, Bin Abdulhak A, Birbeck G, Black JA, Blencowe H, Blore JD, Blyth F, Bolliger I, Bonaventure A, Boufous S, Bourne R, Boussinesq M, Braithwaite T, Brayne C, Bridgett L, Brooker S, Brooks P, Brugha TS, Bryan-Hancock C, Bucello C, Buchbinder R, Buckle G, Budke CM, Burch M, Burney P, Burstein R, Calabria B, Campbell B, Canter CE, Carabin H, Carapetis J, Carmona L, Cella C, Charlson F, Chen H, Cheng AT, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahiya M, Dahodwala N, Damsere-Derry J, Danaei G, Davis A, De Leo D, Degenhardt L, Dellavalle R, Delossantos A, Denenberg J, Derrett S, Des Jarlais DC, Dharmaratne SD, Dherani M, Diaz-Torne C, Dolk H, Dorsey ER, Driscoll T, Duber H, Ebel B, Edmond K, Elbaz A, Ali SE, Erskine H, Erwin PJ, Espindola P, Ewoigbokhan SE, Farzadfar F, Feigin V, Felson DT, Ferrari A, Ferri CP, Fèvre EM, Finucane MM, Flaxman S, Flood L, Foreman K, Forouzanfar MH, Fowkes FG, Franklin R, Fransen M, Freeman MK, Gabbe BJ, Gabriel SE, Gakidou E, Ganatra HA, Garcia B, Gaspari F, Gillum RF, Gmel G, Gosselin R, Grainger R, Groeger J, Guillemin F, Gunnell D, Gupta R, Haagsma J, Hagan H, Halasa YA, Hall W, Haring D, Haro JM, Harrison JE, Havmoeller R, Hay RJ, Higashi H, Hill C, Hoen B, Hoffman H, Hotez PJ, Hoy D, Huang JJ, Ibeanusi SE, Jacobsen KH, James SL, Jarvis D, Jasrasaria R, Jayaraman S, Johns N, Jonas JB, Karthikeyan G, Kassebaum N, Kawakami N, Keren A, Khoo JP, King CH, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lalloo R, Laslett LL, Lathlean T, Leasher JL, Lee YY, Leigh J, Lim SS, Limb E, Lin JK, Lipnick M, Lipshultz SE, Liu W, Loane M, Ohno SL, Lyons R, Ma J, Mabweijano J, MacIntyre MF, Malekzadeh R, Mallinger L, Manivannan S, Marcenes W, March L, Margolis DJ, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGill N, McGrath J, Medina-Mora ME, Meltzer M, Mensah GA, Merriman TR, Meyer AC, Miglioli V, Miller M, Miller TR, Mitchell PB, Mocumbi AO, Moffitt TE, Mokdad AA, Monasta L, Montico M, Moradi-Lakeh M, Moran A, Morawska L, Mori R, Murdoch ME, Mwaniki MK, Naidoo K, Nair MN, Naldi L, Narayan KM, Nelson PK, Nelson RG, Nevitt MC, Newton CR, Nolte S, Norman P, Norman R, O'Donnell M, O'Hanlon S, Olives C, Omer SB, Ortblad K, Osborne R, Ozgediz D, Page A, Pahari B, Pandian JD, Rivero AP, Patten SB, Pearce N, Padilla RP, Perez-Ruiz F, Perico N, Pesudovs K, Phillips D, Phillips MR, Pierce K, Pion S, Polanczyk GV, Polinder S, Pope CA 3rd, Popova S, Porrini E, Pourmalek F, Prince M, Pullan RL, Ramaiah KD, Ranganathan D, Razavi H, Regan M, Rehm JT, Rein DB, Remuzzi G, Richardson K, Rivara FP, Roberts T, Robinson C, De Leòn FR, Ronfani L, Room R, Rosenfeld LC, Rushton L, Sacco RL, Saha S, Sampson U, Sanchez-Riera L, Sanman E, Schwebel DC, Scott JG, Segui-Gomez M, Shahraz S, Shepard DS, Shin H, Shivakoti R, Singh D, Singh GM, Singh JA, Singleton J, Sleet DA, Sliwa K, Smith E, Smith JL, Stapelberg NJ, Steer A, Steiner T, Stolk WA, Stovner LJ, Sudfeld C, Syed S, Tamburlini G, Tavakkoli M, Taylor HR, Taylor JA, Taylor WJ, Thomas B, Thomson WM, Thurston GD, Tleyjeh IM, Tonelli M, Towbin JA, Truelsen T, Tsilimbaris MK, Ubeda C, Undurraga EA, van der Werf MJ, van Os J, Vavilala MS, Venketasubramanian N, Wang M, Wang W, Watt K, Weatherall DJ, Weinstock MA, Weintraub R, Weisskopf MG, Weissman MM, White RA, Whiteford H, Wiersma ST, Wilkinson JD, Williams HC, Williams SR, Witt E, Wolfe F, Woolf AD, Wulf S, Yeh PH, Zaidi AK, Zheng ZJ, Zonies D, Lopez AD, Murray CJ, AlMazroa MA, Memish ZA.

Lancet. 2012 Dec 15;380(9859):2163-96. doi: 10.1016/S0140-6736(12)61729-2. Erratum in: Lancet. 2013 Feb 23;381(9867):628. AlMazroa, Mohammad A [added]; Memish, Ziad A [added].

46.

Single nucleotide polymorphisms in β-tubulin selected in Onchocerca volvulus following repeated ivermectin treatment: possible indication of resistance selection.

Nana-Djeunga H, Bourguinat C, Pion SD, Kamgno J, Gardon J, Njiokou F, Boussinesq M, Prichard RK.

Mol Biochem Parasitol. 2012 Sep;185(1):10-8. doi: 10.1016/j.molbiopara.2012.05.005. Epub 2012 Jun 5.

PMID:
22677339
47.

Loiasis: new epidemiologic insights and proposed treatment strategy.

Boussinesq M.

J Travel Med. 2012 May-Jun;19(3):140-3. doi: 10.1111/j.1708-8305.2012.00605.x. No abstract available.

48.

Significant association between epilepsy and presence of onchocercal nodules: case-control study in Cameroon.

Pion SDS, Boussinesq M.

Am J Trop Med Hyg. 2012 Mar;86(3):557. doi: 10.4269/ajtmh.2012.11-0603a. No abstract available.

49.

Concurrence of dermatological and ophthalmological morbidity in onchocerciasis.

Coffeng LE, Fobi G, Ozoh G, Bissek AC, Nlatté BO, Enyong P, Olinga JM, Zouré HG, Habbema JD, Stolk WA, de Vlas SJ, Boussinesq M, Noma M.

Trans R Soc Trop Med Hyg. 2012 Apr;106(4):243-51. doi: 10.1016/j.trstmh.2011.12.006. Epub 2012 Feb 17.

PMID:
22342170
50.

Case report: Loiasis with peripheral nerve involvement and spleen lesions.

Gobbi F, Boussinesq M, Mascarello M, Angheben A, Gobbo M, Rossanese A, Corachán M, Bisoffi Z.

Am J Trop Med Hyg. 2011 May;84(5):733-7. doi: 10.4269/ajtmh.2011.10-0458.

Supplemental Content

Loading ...
Support Center